Jobs / United States / Astrazeneca Pharmaceuticals Lp
Global Medical Affairs Lead, GI Oncology
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Global Medical Affairs Lead, GI Oncology Location: Gaithersburg, Maryland, United States Working model: Hybrid, with an expected onsite presence three days per week Travel: Approximately 30%, including domestic and international travel Relocation support: May be available Disrupt to redefine cancer treatment At AstraZeneca, we are working to transform cancer care. We follow science, challenge convention and collaborate across boundaries to deliver meaningful advances for patients. Within Medical Affairs, we generate and communicate compelling medical evidence that can change clinical practice and improve the patient experience. By bringing together science and strategy, we help healthcare professionals make informed decisions and accelerate the delivery of innovative medicines to patients. We are seeking a Global Medical Affairs Lead, GI Oncolog y, to provide strategic medical leadership for our expanding hepatobiliary portfolio, including hepatocellular carcinoma and biliary tract cancer. This is an opportunity to shape the medical strategy for a complex and evolving portfolio, prepare global markets for critical launches and contribute to the development of emerging treatment approaches, including next-generation molecules and novel modalities. What you’ll do As the accountable medical leader assigns GI oncology indications and assets, you will shape and deliver the Global Medical Strategy, connecting Medical Affairs, R&D and Commercial teams to advance the portfolio and prepare markets for launch. • Develop and execute Global Medical Plans, setting priorities and adapting strategy based on scientific developments, external insights and performance. • Lead medical launch readiness and ensure global strategies are translated into relevant regional and country plans. • Influence clinical development, evidence generation and lifecycle planning by representing Medical Affairs on key cross-functional teams. • Identify evidence gaps and lead integrated evidence plans across clinical, real-world, diagnostic and digital sources. • Shape Medical Affairs studies and lead global publication and scientific communication strategies. • Develop a clear scientific narrative across publications, medical education, congresses and external engagement. • Build strategic relationships with external experts, professional societies, health systems and other scientific organizations. • Lead complex global matrix teams, build stakeholder alignment and strengthen Medical Affairs capabilities through coaching and mentorship. Essential requirements • Advanced medical or scientific degree, such as an MD, PhD, PharmD or equivalent. • +3 years of Medical Affairs experience within the pharmaceutical or biotechnology industry, typically gained at country, regional or global level. • +3 years of demonstrated experience in oncology. • +3 years of experience developing or leading Medical Plans, evidence-generation strategies, publications or scientific communication programs. • +3 years of experience supporting an oncology launch or preparing a market for launch • Demonstrated success working in a complex, cross-functional matrix involving Medical Affairs, R&D and Commercial stakeholders. • Proven ability to influence senior stakeholders and translate scientific evidence into strategic recommendations. • Experience engaging external experts and scientific communities. • Strong scientific communication, stakeholder-management and leadership skills. Desirable qualifications • Experience in gastrointestinal oncology, hepatocellular carcinoma, biliary tract cancer or another hepatobiliary malignancy. • Experience in immuno-oncology or immunotherapy. • Experience with new mechanisms of action, emerging treatment modalities, companion diagnostic